Diametric Capital’s Achieve Life Sciences ACHV Stock Holding History

Diametric Capital’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.8K	Buy	+18,651	New	+$82.8K	0.01%	451
2024 Q1	–	Sell	-18,753	Closed	-$77.3K	–	326
2023 Q4	$77.3K	Sell	18,753 -60,457	-76%	-$263K	0.05%	231
2023 Q3	$341K	Sell	79,210 -4,868	-6%	-$24.5K	0.14%	201
2023 Q2	$436K	Buy	84,078 +37,679	+81%	+$264K	0.19%	144
2023 Q1	$316K	Buy	46,399 +26,496	+133%	+$126K	0.15%	193
2022 Q4	$48.8K	Sell	19,903 -14,757	-43%	-$37.9K	0.02%	266
2022 Q3	$114K	Buy	34,660 +15,153	+78%	+$72.3K	0.06%	235
2022 Q2	$95K	Buy	+19,507	New	+$132K	0.07%	225

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diametric Capital's ACHV Position: Q1 2026 in Review

Diametric Capital opened a new position in Achieve Life Sciences (ACHV) in Q1 2026: 18,651 shares worth $54.8K. The stake represents 0.01% of the portfolio and ranks #451 among its holdings. This is a return to the name: Diametric Capital previously reported a position in ACHV as recently as Q4 2023.

Diametric Capital first reported a position in ACHV in Q2 2022 and has held it in 8 quarters since. The position peaked at $436K in Q2 2023. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Diametric Capital held 18,651 shares of Achieve Life Sciences worth $54.8K as of Q1 2026.
Achieve Life Sciences was a new Diametric Capital position in Q1 2026.
Achieve Life Sciences made up 0.01% of Diametric Capital's portfolio in Q1 2026, its #451 holding.
Diametric Capital first reported a position in Achieve Life Sciences in Q2 2022 and has held it in 8 quarters since.
Diametric Capital's Achieve Life Sciences position peaked at $436K in Q2 2023.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.